<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36958798</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>12</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1936-959X</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>AJNR. American journal of neuroradiology</Title><ISOAbbreviation>AJNR Am J Neuroradiol</ISOAbbreviation></Journal><ArticleTitle>Clinical Profiles and Patterns of Neurodegeneration in Amyotrophic Lateral Sclerosis: A Cluster-Based Approach Based on MR Imaging Metrics.</ArticleTitle><Pagination><StartPage>403</StartPage><EndPage>409</EndPage><MedlinePgn>403-409</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3174/ajnr.A7823</ELocationID><Abstract><AbstractText Label="BACKGROUND AND PURPOSE">The previous studies described phenotype-associated imaging findings in amyotrophic lateral sclerosis (ALS) with a prior categorization of patients based on clinical characteristics. We investigated the natural segregation of patients through a radiologic cluster-based approach without a priori patient categorization using 3 well-known prognostic MR imaging biomarkers in ALS, namely bilateral precentral and paracentral gyrus cortical thickness and medulla oblongata volume. We aimed to identify clinical/prognostic features that are cluster-associated.</AbstractText><AbstractText Label="MATERIALS AND METHODS">Bilateral precentral and paracentral gyri and medulla oblongata volume were calculated using FreeSurfer in 90 patients with amyotrophic lateral sclerosis and 25 healthy controls. A 2-step cluster analysis was performed using precentral and paracentral gyri (averaged pair-wise) and medulla oblongata volume.</AbstractText><AbstractText Label="RESULTS">We identified 3 radiologic clusters: 28 (31%) patients belonged to "cluster-1"; 51 (57%), to "cluster 2"; and 11 (12%), to "cluster 3." Patients in cluster 1 showed statistically significant cortical thinning of the analyzed cortical areas and lower medulla oblongata volume compared with subjects in cluster 2 and cluster 3, respectively. Patients in cluster 3 exhibited significant cortical thinning of both paracentral and precentral gyri versus those in cluster 2, and this latter cluster showed lower medulla oblongata volume than cluster 3. Patients in cluster 1 were characterized by older age, higher female prevalence, greater disease severity, higher progression rate, and lower survival compared with patients in clusters 2 and 3.</AbstractText><AbstractText Label="CONCLUSIONS">Patients with amyotrophic lateral sclerosis spontaneously segregate according to age and sex-specific patterns of neurodegeneration. Some patients with amyotrophic lateral sclerosis showed an early higher impairment of cortical motor neurons with relative sparing of bulbar motor neurons (cluster 3), while others expressed an opposite pattern (cluster 2). Moreover, 31% of patients showed an early simultaneous impairment of cortical and bulbar motor neurons (cluster 1), and they were characterized by higher disease severity and lower survival.</AbstractText><CopyrightInformation>&#xa9; 2023 by American Journal of Neuroradiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Milella</LastName><ForeName>G</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-7612-382X</Identifier><AffiliationInfo><Affiliation>From the Neurology Unit (G.M., A.I., D.M.M., E.D., A.F., M.U., I.L.S.), Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari "Aldo Moro," Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Introna</LastName><ForeName>A</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3141-6442</Identifier><AffiliationInfo><Affiliation>From the Neurology Unit (G.M., A.I., D.M.M., E.D., A.F., M.U., I.L.S.), Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari "Aldo Moro," Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mezzapesa</LastName><ForeName>D M</ForeName><Initials>DM</Initials><Identifier Source="ORCID">0000-0002-5098-6379</Identifier><AffiliationInfo><Affiliation>From the Neurology Unit (G.M., A.I., D.M.M., E.D., A.F., M.U., I.L.S.), Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari "Aldo Moro," Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Errico</LastName><ForeName>E</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-3762-5800</Identifier><AffiliationInfo><Affiliation>From the Neurology Unit (G.M., A.I., D.M.M., E.D., A.F., M.U., I.L.S.), Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari "Aldo Moro," Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fraddosio</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Neurology Unit (G.M., A.I., D.M.M., E.D., A.F., M.U., I.L.S.), Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari "Aldo Moro," Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ucci</LastName><ForeName>M</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2956-4849</Identifier><AffiliationInfo><Affiliation>From the Neurology Unit (G.M., A.I., D.M.M., E.D., A.F., M.U., I.L.S.), Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari "Aldo Moro," Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zoccolella</LastName><ForeName>S</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-4037-7630</Identifier><AffiliationInfo><Affiliation>Azienda Sanitaria Locale Bari (S.Z.), San Paolo Hospital, Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simone</LastName><ForeName>I L</ForeName><Initials>IL</Initials><Identifier Source="ORCID">0000-0002-7429-3091</Identifier><AffiliationInfo><Affiliation>From the Neurology Unit (G.M., A.I., D.M.M., E.D., A.F., M.U., I.L.S.), Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari "Aldo Moro," Bari, Italy isabellalaura.simone@uniba.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>AJNR Am J Neuroradiol</MedlineTA><NlmUniqueID>8003708</NlmUniqueID><ISSNLinking>0195-6108</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000082643" MajorTopicYN="N">Cerebral Cortical Thinning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009044" MajorTopicYN="Y">Motor Cortex</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>23</Day><Hour>21</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36958798</ArticleId><ArticleId IdType="pmc">PMC10084907</ArticleId><ArticleId IdType="doi">10.3174/ajnr.A7823</ArticleId><ArticleId IdType="pii">ajnr.A7823</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chi&#xf2; A, Calvo A, Moglia C, et al. . Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry 2011;82:740&#x2013;46 10.1136/jnnp.2010.235952</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.235952</ArticleId><ArticleId IdType="pubmed">21402743</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang T, Al Khleifat A, Stahl DR, et al. . Comparison of the King&#x2019;s and MiToS staging systems for ALS. Amyotroph Lateral Scler Fronttotemporal Degener 2017;18:227&#x2013;32 10.1080/21678421.2016.1265565</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1265565</ArticleId><ArticleId IdType="pmc">PMC5425622</ArticleId><ArticleId IdType="pubmed">28054828</ArticleId></ArticleIdList></Reference><Reference><Citation>Tramacere I, Dalla Bella E, Chi&#xf2; A, et al. . The MITOS system predicts long-term survival in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2015;86:1180&#x2013;85 10.1136/jnnp-2014-310176</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2014-310176</ArticleId><ArticleId IdType="pubmed">25886781</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, et al. ; World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrop Lateral Scler Motor Neuron Disord 2000;1:293&#x2013;99 10.1080/146608200300079536</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong MJ, Abrahams S, Goldstein LH, et al. . Amyotrophic lateral sclerosis: frontotemporal spectrum disorder (ALS-FTSD)&#x2014;revised diagnostic criteria. Amyotroph Lateral Scler Fronteporal Degener 2017;18:153&#x2013;74 10.1080/21678421.2016.1267768</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1267768</ArticleId><ArticleId IdType="pmc">PMC7409990</ArticleId><ArticleId IdType="pubmed">28054827</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R, Jones A, Jivraj N, et al. ; UK-MND LiCALS Study Group, Mito Target ALS Study Group. Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials. J Neurol Neurosurg Psychiatry 2015;86:45&#x2013;49 10.1136/jnnp-2013-306865</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-306865</ArticleId><ArticleId IdType="pubmed">24463480</ArticleId></ArticleIdList></Reference><Reference><Citation>Introna A, Milella G, Morea A, et al. . King&#x2019;s College progression rate at first clinical evaluation: a new measure of disease progression in amyotrophic lateral sclerosis. J Neurol Sci 2021;431:120041 10.1016/j.jns.2021.120041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2021.120041</ArticleId><ArticleId IdType="pubmed">34736124</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R, Al Khleifat A, Fang T, et al. . A standard operating procedure for King&#x2019;s ALS clinical staging. Amyotroph Lateral Scler Fronteporal 2019;20:159&#x2013;64 10.1080/21678421.2018.1556696</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1556696</ArticleId><ArticleId IdType="pmc">PMC6558284</ArticleId><ArticleId IdType="pubmed">30773950</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakers JN, de Jongh AD, Bunte TM, et al. . Using the ALSFRS-R in multicentre clinical trials for amyotrophic lateral sclerosis: potential limitations in current standard operating procedures. Amyotroph Lateral Scler Fronteporal 2021;23;500&#x2013;07 10.1080/21678421.2021.2016838</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2021.2016838</ArticleId><ArticleId IdType="pubmed">34949141</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaiani A, Martinelli I, Bello L, et al. . Diagnostic and prognostic biomarkers in amyotrophic lateral sclerosis: neurofilament light chain levels in definite subtypes of disease. JAMA Neurol 2017;74:525&#x2013;32 10.1001/jamaneurol.2016.5398</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2016.5398</ArticleId><ArticleId IdType="pmc">PMC5822207</ArticleId><ArticleId IdType="pubmed">28264096</ArticleId></ArticleIdList></Reference><Reference><Citation>Scarafino A, D&#x2019;Errico E, Introna A, et al. . Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosis. J Neurol 2018;265:2353&#x2013;62 10.1007/s00415-018-9008-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-018-9008-3</ArticleId><ArticleId IdType="pubmed">30116940</ArticleId></ArticleIdList></Reference><Reference><Citation>Verber NS, Shepheard SR, Sassani M, et al. . Biomarkers in motor neuron disease: a state of the art review. Front Neurol 2019;10:291 10.3389/fneur.2019.00291</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00291</ArticleId><ArticleId IdType="pmc">PMC6456669</ArticleId><ArticleId IdType="pubmed">31001186</ArticleId></ArticleIdList></Reference><Reference><Citation>Grolez G, Moreau C, Danel-Brunaud V, et al. . The value of magnetic resonance imaging as a biomarker for amyotrophic lateral sclerosis: a systematic review. BMC Neurol 2016;16:155 10.1186/s12883-016-0672-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-016-0672-6</ArticleId><ArticleId IdType="pmc">PMC5002331</ArticleId><ArticleId IdType="pubmed">27567641</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F, Valsasina P, Riva N, et al. . The cortical signature of amyotrophic lateral sclerosis. PLoS One 2012;7:e42816 10.1371/journal.pone.0042816</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0042816</ArticleId><ArticleId IdType="pmc">PMC3412820</ArticleId><ArticleId IdType="pubmed">22880116</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster C, Kasper E, Machts J, et al. . Focal thinning of the motor cortex mirrors clinical features of amyotrophic lateral sclerosis and their phenotypes: a neuroimaging study. J Neurol 2013;260:2856&#x2013;64 10.1007/s00415-013-7083-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-013-7083-z</ArticleId><ArticleId IdType="pubmed">23996101</ArticleId></ArticleIdList></Reference><Reference><Citation>Walhout R, Westeneng H-J, Verstraete E, et al. . Cortical thickness in ALS: towards a marker for upper motor neuron involvement. J Neurol Neurosurg Psychiatry 2015;86:288&#x2013;94 10.1136/jnnp-2013-306839]</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-306839]</ArticleId><ArticleId IdType="pubmed">25121571</ArticleId></ArticleIdList></Reference><Reference><Citation>Mezzapesa DM, D&#x2019;Errico E, Tortelli R, et al. . Cortical thinning and clinical heterogeneity in amyotrophic lateral sclerosis. PLoS One 2013;8:e80748 10.1371/journal.pone.0080748</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0080748</ArticleId><ArticleId IdType="pmc">PMC3835750</ArticleId><ArticleId IdType="pubmed">24278317</ArticleId></ArticleIdList></Reference><Reference><Citation>Distaso E, Milella G, Mezzapesa DM, et al. . Magnetic resonance metrics to evaluate the effect of therapy in amyotrophic lateral sclerosis: the experience with edaravone. J Neurol 2021;268:3307&#x2013;15 10.1007/s00415-021-10495-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10495-9</ArticleId><ArticleId IdType="pmc">PMC8357666</ArticleId><ArticleId IdType="pubmed">33655342</ArticleId></ArticleIdList></Reference><Reference><Citation>Senda J, Kato S, Kaga T, et al. . Progressive and widespread brain damage in ALS: MRI voxel-based morphometry and diffusion tensor imaging study. Amyotroph Lateral Scler 2011;12:59&#x2013;69 10.3109/17482968.2010.517850</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2010.517850</ArticleId><ArticleId IdType="pubmed">21271792</ArticleId></ArticleIdList></Reference><Reference><Citation>Milella G, Introna A, Ghirelli A, et al. . Medulla oblongata volume as a promising predictor of survival in amyotrophic lateral sclerosis. Neuroimage Clin 2022;34:103015 10.1016/j.nicl.2022.103015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2022.103015</ArticleId><ArticleId IdType="pmc">PMC9111981</ArticleId><ArticleId IdType="pubmed">35561555</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Zhang Q, Duan Q, et al. . Brainstem involvement in amyotrophic lateral sclerosis: a combined structural and diffusion tensor MRI analysis. Front. Neurosci 2021;15:675444 10.3389/fnins.2021.675444</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2021.675444</ArticleId><ArticleId IdType="pmc">PMC8206526</ArticleId><ArticleId IdType="pubmed">34149349</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster C, Hardiman O, Bede P. Survival prediction in amyotrophic lateral sclerosis based on MRI measures and clinical characteristics. BMC Neurol 2017;17:73 10.1186/s12883-017-0854-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-017-0854-x</ArticleId><ArticleId IdType="pmc">PMC5393027</ArticleId><ArticleId IdType="pubmed">28412941</ArticleId></ArticleIdList></Reference><Reference><Citation>Finegan E, Li Hi Shing S, Chipika RH, et al. . Widespread subcortical grey matter degeneration in primary lateral sclerosis: a multimodal imaging study with genetic profiling. Neuroimage Clin 2019;24:102089 10.1016/j.nicl.2019.102089</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2019.102089</ArticleId><ArticleId IdType="pmc">PMC6978214</ArticleId><ArticleId IdType="pubmed">31795059</ArticleId></ArticleIdList></Reference><Reference><Citation>Consonni M, Dalla Bella E, Contarino VE, et al. . Cortical thinning trajectories across disease stages and cognitive impairment in amyotrophic lateral sclerosis. Cortex 2020;131:284&#x2013;94 10.1016/j.cortex.2020.07.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cortex.2020.07.007</ArticleId><ArticleId IdType="pubmed">32811660</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrea S, Junker F, Korth M, et al. . Cortical thinning of motor and non-motor brain regions enables diagnosis of amyotrophic lateral sclerosis and supports distinction between upper- and lower-motoneuron phenotypes. Biomedicines 2021;9:1195 10.3390/biomedicines9091195</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9091195</ArticleId><ArticleId IdType="pmc">PMC8468309</ArticleId><ArticleId IdType="pubmed">34572380</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Murad A, Lope J, et al. . Clusters of anatomical disease-burden patterns in ALS: a data-driven approach confirms radiological subtypes. J Neurol 2022;268:4404&#x2013;13 10.1007/s00415-022-11081-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-022-11081-3</ArticleId><ArticleId IdType="pmc">PMC9294023</ArticleId><ArticleId IdType="pubmed">35333981</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan HH, Westeneng HJ, Nitert AD, et al. . MRI clustering reveals three ALS subtypes with unique neurodegeneration patterns. Ann Neurol 2022;92:1030&#x2013;45 10.1002/ana.26488</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26488</ArticleId><ArticleId IdType="pmc">PMC9826424</ArticleId><ArticleId IdType="pubmed">36054734</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E, et al. . The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function&#x2014;BDNF ALS Study Group (Phase III). J Neurol Sci 1999;169:13&#x2013;21 10.1016/s0022-510x(99)00210-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-510x(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura F, Fujimura C, Ishida S, et al. . Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology 2006;66:265&#x2013;67 10.1212/01.wnl.0000194316.91908.8a</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000194316.91908.8a</ArticleId><ArticleId IdType="pubmed">16434671</ArticleId></ArticleIdList></Reference><Reference><Citation>Grachev ID, Berdichevsky D, Rauch SL, et al. . A method for assessing the accuracy of intersubject registration of the human brain using anatomic landmarks. Neuroimage 1999;9:250&#x2013;68 10.1006/nimg.1998.0397</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nimg.1998.0397</ArticleId><ArticleId IdType="pubmed">9927554</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutton C, Draganski B, Ashburner J, et al. . A comparison between voxel-based cortical thickness and voxel-based morphometry in normal aging. Neuroimage 2009;48:371&#x2013;80 10.1016/j.neuroimage.2009.06.043</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2009.06.043</ArticleId><ArticleId IdType="pmc">PMC2741580</ArticleId><ArticleId IdType="pubmed">19559801</ArticleId></ArticleIdList></Reference><Reference><Citation>Iglesias JE, Van Leemput K, Bhatt P, et al. ; Alzheimer&#x2019;s Disease Neuroimaging Initiative. Bayesian segmentation of brainstem structures in MRI. NeuroImage 2015;113:184&#x2013;95 10.1016/j.neuroimage.2015.02.065</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2015.02.065</ArticleId><ArticleId IdType="pmc">PMC4434226</ArticleId><ArticleId IdType="pubmed">25776214</ArticleId></ArticleIdList></Reference><Reference><Citation>Pintzka C, Hansen TI, Evensmoen H, et al. . Marked effects of intracranial volume correction methods on sex differences in neuroanatomical structures: a HUNT MRI study. Front Neurosci 2015;9:238 10.3389/fnins.2015.00238</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2015.00238</ArticleId><ArticleId IdType="pmc">PMC4496575</ArticleId><ArticleId IdType="pubmed">26217172</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinbach R, Prell T, Gaur N, et al. . Patterns of grey and white matter changes differ between bulbar and limb onset amyotrophic lateral sclerosis. Neuroimage Clin 2021;30:102674 10.1016/j.nicl.2021.102674</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2021.102674</ArticleId><ArticleId IdType="pmc">PMC8099783</ArticleId><ArticleId IdType="pubmed">33901988</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Mao C, Jin J, et al. . Side of limb-onset predicts laterality of gray matter loss in amyotrophic lateral sclerosis. BioMed Res Int 2014;2014:e473250 10.1155/2014/473250</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/473250</ArticleId><ArticleId IdType="pmc">PMC4100370</ArticleId><ArticleId IdType="pubmed">25093168</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabiano AJ, Horsfield MA, Bakshi R. Interhemispheric asymmetry of brain diffusivity in normal individuals: a diffusion-weighted MR imaging study. AJNR Am J Neuroradiol 2005;26:1089&#x2013;94</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8158621</ArticleId><ArticleId IdType="pubmed">15891165</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Elamin M, Byrne S, et al. . Sexual dimorphism in ALS: exploring gender-specific neuroimaging signatures. Amyotroph Lateral Scler Frontotemporal Degener 2014;15:235&#x2013;43 10.3109/21678421.2013.865749</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.865749</ArticleId><ArticleId IdType="pubmed">24344910</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu T, Fang D, Chen J, et al. . A robust and scalable clustering algorithm for mixed type attributes in large database environment. In: Proceedings of the seventh ACM SIGKDD international conference on knowledge discovery and data mining. New York, New York, August 2001:263&#x2013;68 10.1145/502512.502549</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/502512.502549</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufman L, Rousseuw PJ. Finding groups in data: an introduction to cluster analysis. Biometrics 1991;47:788 10.2307/2532178</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/2532178</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinelli EG, Riva N, Rancoita PMV, et al. . Structural MRI outcomes and predictors of disease progression in amyotrophic lateral sclerosis. Neuroimage Clin 2020;27:102315 10.1016/j.nicl.2020.102315</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2020.102315</ArticleId><ArticleId IdType="pmc">PMC7327879</ArticleId><ArticleId IdType="pubmed">32593977</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, Del Tredici K, Toledo JB, et al. . Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol 2013;74:20&#x2013;38 10.1002/ana.23937</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23937</ArticleId><ArticleId IdType="pmc">PMC3785076</ArticleId><ArticleId IdType="pubmed">23686809</ArticleId></ArticleIdList></Reference><Reference><Citation>Schito P, Spinelli EG, Malvaso A, et al. . Primary lateral sclerosis presenting with focal onset spreading through contiguous neuroanatomic regions. Neurology 2022;98:503&#x2013;04 10.1212/WNL.0000000000200011</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000200011</ArticleId><ArticleId IdType="pubmed">35131910</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits J. Focality, stochasticity and neuroanatomic propagation in ALS pathogenesis. Exp Neurol 2014;262:121&#x2013;26 10.1016/j.expneurol.2014.07.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2014.07.021</ArticleId><ArticleId IdType="pubmed">25108067</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekiguchi T, Kanouchi T, Shibuya K, et al. . Spreading of amyotrophic lateral sclerosis lesions&#x2013;multifocal hits and local propagation? J Neurol Neurosurg Psychiatry 2014;85:85&#x2013;91 10.1136/jnnp-2013-305617</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-305617</ArticleId><ArticleId IdType="pubmed">24027298</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraro PM, Cabona C, Meo G, et al. . Age at symptom onset influences cortical thinning distribution and survival in amyotrophic lateral sclerosis. Neuroradiology 2021;63:1481&#x2013;87 10.1007/s00234-021-02681-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00234-021-02681-3</ArticleId><ArticleId IdType="pubmed">33660067</ArticleId></ArticleIdList></Reference><Reference><Citation>Angenstein F, Niessen HG, Goldschmidt J, et al. . Age-dependent changes in MRI of motor brain stem nuclei in a mouse model of ALS. Neuroreport 2004;15:2271&#x2013;74 10.1097/00001756-200410050-00026]</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-200410050-00026]</ArticleId><ArticleId IdType="pubmed">15371748</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraro PM, Campi C, Miceli A, et al. . 18F-FDG-PET correlates of aging and disease course in ALS as revealed by distinct PVC approaches. Eur J Radiol Open 2022;9:100394 10.1016/j.ejro.2022.100394</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejro.2022.100394</ArticleId><ArticleId IdType="pmc">PMC8760536</ArticleId><ArticleId IdType="pubmed">35059473</ArticleId></ArticleIdList></Reference><Reference><Citation>Trojsi F, Di Nardo F, Caiazzo G, et al. . Between-sex variability of resting state functional brain networks in amyotrophic lateral sclerosis (ALS). J Neural Transm (Vienna) 1996. 2021;128:1881&#x2013;97 10.1007/s00702-021-02413-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-021-02413-0</ArticleId><ArticleId IdType="pmc">PMC8571222</ArticleId><ArticleId IdType="pubmed">34471976</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Moglia C, Canosa A, et al. . ALS phenotype is influenced by age, sex, and genetics: a population-based study. Neurology 2020;94:e802&#x2013;10 10.1212/WNL.0000000000008869</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000008869</ArticleId><ArticleId IdType="pubmed">31907290</ArticleId></ArticleIdList></Reference><Reference><Citation>Finegan E, Chipika RH, Li Hi Shing S, et al. . The clinical and radiological profile of primary lateral sclerosis: a population-based study. J Neurol 2019;266:2718&#x2013;33 10.1007/s00415-019-09473-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09473-z</ArticleId><ArticleId IdType="pubmed">31325016</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahedl M, Li H, Shing S, Finegan E, et al. . Propagation patterns in motor neuron diseases: Individual and phenotype-associated disease-burden trajectories across the UMN-LMN spectrum of MNDs. Neurobiol Aging 2022;109:78&#x2013;87 10.1016/j.neurobiolaging.2021.04.03]1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2021.04.03]1</ArticleId><ArticleId IdType="pubmed">34656922</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>